AMA submission to the Therapeutic Goods Administration - proposed amendments to the Poisons Standard – June 2020

19 May 2020

In this submission, the AMA provides feedback to the medicine scheduling proposals for June 2020. The AMA does not oppose the proposed changes to oxymetazoline, clotrimazole, cumyl-pegaclone, nicotine, methylisothiazolinone and methylchloroisothiazolinone, and isothiazolinones. The AMA supports increased access to eletriptan. The AMA opposes the proposed changes to sildenafil, ibuprofen, and cannabidiol.